Low Diagnostic Specificity of Alternative Mast Cell Activation Syndrome Criteria
Author Information
Author(s): Solomon Benjamin D. MD, PhD, Khatri Purvesh PhD
Primary Institution: Stanford University
Hypothesis
Do alternative MCAS criteria result in less concise or consistent diagnostic alternatives, reducing diagnostic specificity?
Conclusion
Alternative MCAS criteria are associated with a distinct set of diagnoses compared to consortium MCAS criteria and have lower diagnostic consistency.
Supporting Evidence
- Alternative MCAS criteria are associated with more variable diagnoses compared to consortium MCAS criteria.
- The Shannon diversity of alternative MCAS criteria diagnoses was significantly higher than consortium MCAS criteria diagnoses.
- Alternative MCAS criteria overlap with a highly variable range of possible diagnoses.
Takeaway
The study shows that using different criteria for diagnosing mast cell activation syndrome can lead to confusion and misdiagnosis because they are not as specific.
Methodology
The study used large language models to analyze the diagnostic precision and specificity of consortium and alternative MCAS criteria.
Potential Biases
The use of alternative criteria may lead to overdiagnosis and mismanagement of patients.
Limitations
The training data for large language models includes a wide range of public text sources, which may not be restricted to medical literature.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website